F18.229
Inhalant dependence with intoxication, unspecified
Clinical Classification Guidelines
Medical Intelligence & Overview
Inhalant dependence with intoxication, classified under ICD-10 code F18.229, is a condition characterized by a compulsive need to use inhalants and the resulting intoxication. Inhalants are substances whose fumes are sniffed or inhaled to produce mind-altering effects. This condition can lead to serious health complications and requires awareness for proper identification and management.
Causes & Symptoms
Clinical Causes: Repeated exposure to volatile substances such as solvents, aerosols, gases, and nitrates commonly found in household or industrial products. Psychological factors including stress, peer pressure, or a desire to experience euphoria. Underlying mental health conditions like depression or anxiety that increase vulnerability to substance dependence. Environmental influences, including availability and social environment where inhalant use is prevalent.
Key Symptoms: Craving or a strong desire to use inhalants. Using inhalants repeatedly or compulsively despite negative consequences. Sudden or frequent episodes of intoxication characterized by euphoria, dizziness, or disorientation. Impaired judgment or coordination during episodes of inhalant use. Physical signs such as chemical smells on breath or clothing, redness or sores around the mouth, or sudden loss of consciousness. Memory problems or difficulty concentrating. Mood swings, irritability, or depression associated with withdrawal or ongoing use.
Diagnostic & Treatment
Diagnosis Path: Diagnosis primarily involves a comprehensive clinical evaluation by a healthcare professional, including a detailed history of substance use and physical examinations. Laboratory tests such as blood or urine analysis may help detect inhalant substances or their metabolites. Mental health assessments may also be conducted to evaluate the psychological aspects of dependence.
Treatment Protocols: Detoxification under medical supervision to manage withdrawal symptoms. Psychotherapy, such as cognitive-behavioral therapy (CBT), to address behavioral patterns and develop coping strategies. Counseling and support groups to foster ongoing recovery and provide emotional support. Medical management for any acute health risks or chronic issues resulting from inhalant use. Educational programs to raise awareness and prevent relapse. Family therapy may also be beneficial to support the individual's recovery process.
Clinical Advice & FAQs
Billing Guidance
Is F18.229 a billable ICD-10 code?
Yes, F18.229 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report F18.229?
Clinical documentation must specify the nature of Inhalant dependence with intoxication, unspecified and any associated comorbidities for accurate reporting.
Cite this Clinical Reference
